Molluscum contagiosum
Conditions
Interventions
This is a randomized, controlled, two-arm, double-blind clinical trial. A total of 58 children who meet the eligibility criteria will be probabilistically allocated to one or the other intervention gr
Sponsors
Escola Paulista de Medicina da Universidade Federal de São Paulo
Universidade Federal do Piauí
Eligibility
Age
1 Years to 12 Years
Inclusion criteria
Inclusion criteria: Patients with a clinical diagnosis of molluscum contagiosum, without perimolluscal eczema; aged between one and twelve years; of both sexes; whose parents or legal guardians have signed an informed consent form
Exclusion criteria
Exclusion criteria: Individuals with congenital or acquired immunosuppression; children who have used another treatment in the last month; patients with lesions on the face or genital region; children with allergies to the components of the medications
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Complete clearance (disappearance of molluscum contagiosum lesions) is expected. The patient will be considered cured if he or she does not have lesions in any of the treated areas. | — |
Secondary
| Measure | Time frame |
|---|---|
| It is expected to observe the percentage of reducing contagious mollusk lesions using 10% silver nitrate in aqueous solution and using 10% potassium hydroxide in aqueous solidation, as well as finding the adverse effects/tolerability of these medications. | — |
Countries
Brazil
Contacts
Public ContactCarla Riama Moura
Universidade Federal de São Paulo
Outcome results
None listed